Peer reviewed by medical experts that included three U.S. government senior scientists and published in the American Journal of Therapeutics, the research is the most comprehensive review of the available...

By NewsDesk  @infectiousdiseasenews Biopharmaceutical company, Tarsus Pharmaceuticals, recently announced that the U.S. Food and Drug Administration (FDA) has accepted the Company’s Investigational...

By Teddy Cambosa The Department of Health (DOH) and the Department of Science and Technology (DOST) must fast-track the clinical trials on the use of the antiparasitic drug Ivermectin, according to Rep....

A new antibiotic compound clears infection of multi-drug resistant gonorrhea in mice in a single oral dose, according to a new study led by researchers at Penn State and Emory University. The compound...

Melinta Therapeutics, LLC (Melinta), today announced that the U.S. Food and Drug Administration (FDA) has approved KIMYRSA™ (oritavancin)  for the treatment of adult patients with acute bacterial skin...

A year ago, infectious disease doctor Christine Johnston was leading a study on the use of hydroxychloroquine for the treatment of people with COVID-19. The trial launched at the end of March, when the...

According to a study published in JAMA today, researchers from the Centro de Estudios en Infectologia Pediatrica in Cali, Colombia looked at the effect of Ivermectin on time to resolution of symptoms...

By NewsDesk  @bactiman63 Aridis Pharmaceuticals, Inc., a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening infections, announced...

Ebola and Marburg are among the most deadly viruses, with mortality rates from these infections ranging from 25% to 90%. While no drugs currently are available on the market to prevent infection from these...

By News Desk  @bactiman63 The Ministerial Advisory Committee (MAC) on COVID-19 in South Africa released a memo recently concerning the use of ivermectin for the prevention or treatment of COVID-19. The...